Orange Book product · Brand (NDA)
NORPACE CR
DISOPYRAMIDE PHOSPHATE
At a glance
Jul 20, 1982
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jul 20, 1982
44 yr 7 mo ago
Today
Pharmaceutical detail
Active ingredient
DISOPYRAMIDE PHOSPHATE
Strength
EQ 150MG BASE
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
TE code
Not listed
Application
NDA 018655
Product number
002
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- —NORPACEBrand (NDA)
NDA 017447 · PFIZER
- 1987DISOPYRAMIDE PHOSPHATEGeneric (ANDA)
ANDA 071200 · NESHER PHARMS
- 1987DISOPYRAMIDE PHOSPHATEGeneric (ANDA)
ANDA 070940 · SUPERPHARM
- 1987DISOPYRAMIDE PHOSPHATEGeneric (ANDA)
ANDA 070941 · SUPERPHARM
- 1987DISOPYRAMIDE PHOSPHATEGeneric (ANDA)
ANDA 071190 · INTERPHARM
- 1987DISOPYRAMIDE PHOSPHATEGeneric (ANDA)
ANDA 071191 · INTERPHARM
- 1986DISOPYRAMIDE PHOSPHATEGeneric (ANDA)
ANDA 070240 · WATSON LABS
- 1986DISOPYRAMIDE PHOSPHATEGeneric (ANDA)
ANDA 070241 · WATSON LABS
- 1985DISOPYRAMIDE PHOSPHATEGeneric (ANDA)
ANDA 070351 · SUN PHARM INDUSTRIES
- 1985DISOPYRAMIDE PHOSPHATEGeneric (ANDA)
ANDA 070352 · SUN PHARM INDUSTRIES
- 1985DISOPYRAMIDE PHOSPHATEGeneric (ANDA)
ANDA 070470 · RISING
- 1985DISOPYRAMIDE PHOSPHATEGeneric (ANDA)
ANDA 070471 · RISING
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

